文献速递心脑血管急症消化、代谢与肾脏急症

入院高血压对强化降压治疗脑出血患者急性肾损伤发生率的影响

Impact of Admission Hypertension on Rates of Acute Kidney Injury in Intracerebral Hemorrhage Treated with Intensive Blood Pressure Control.
PubMed 文献 · Neurocrit Care · 2018-01-01
一句话结论脑出血患者入院收缩压≥220 mmHg时,强化降压(收缩压≤140 mmHg)后急性肾损伤风险独立增加(OR 2.6,p<0.001)。

该回顾性队列研究纳入401例接受强化降压(收缩压≤140 mmHg)的脑出血患者,按入院收缩压分为轻度(141-179 mmHg,177例)、中度(180-219 mmHg,124例)和重度(≥220 mmHg,100例)三组。结果显示急性肾损伤患病率在三组间存在显著差异(p<0.001),重度高血压组发生率最高。重度高血压可独立预测急性肾损伤发生(OR 2.6;p<0.001)。作者认为,对于入院收缩压较高的脑出血患者,需进一步研究以确定最合适的血压管理策略。

要点

  • 入院收缩压≥220 mmHg的脑出血患者,强化降压(收缩压≤140 mmHg)后急性肾损伤发生率最高(p<0.001)。
  • 重度高血压(收缩压≥220 mmHg)独立预测急性肾损伤发生(OR 2.6;p<0.001)。
  • 研究纳入401例脑出血患者,轻度(141-179 mmHg)177例、中度(180-219 mmHg)124例、重度(≥220 mmHg)100例。
  • 作者指出,对于入院收缩压较高的脑出血患者,需进一步研究以确定最合适的血压管理策略。

适用人群与场景

  • 接受强化降压(收缩压≤140 mmHg)的脑出血患者。
  • 按入院收缩压分为三组:轻度(收缩压141-179 mmHg)、中度(收缩压180-219 mmHg)、重度(收缩压≥220 mmHg)。

处置流程与药物剂量

  • 对脑出血患者进行强化血压控制,目标收缩压≤140 mmHg。

研究设计与关键结果

  • 研究类型:回顾性队列研究;样本量:401例;人群:接受强化降压(收缩压≤140 mmHg)的脑出血患者。
  • 分组:轻度高血压(收缩压141-179 mmHg)177例,中度高血压(收缩压180-219 mmHg)124例,重度高血压(收缩压≥220 mmHg)100例。
  • 主要结果:急性肾损伤患病率在三组间显著增加(p<0.001),重度高血压组发生率最高。
  • 重度高血压独立预测急性肾损伤发生(OR 2.6;p<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于入院收缩压≥220 mmHg的脑出血患者,强化降压(收缩压≤140 mmHg)时需关注急性肾损伤风险(OR 2.6;p<0.001)。
  • 作者认为,对于入院收缩压较高的脑出血患者,需进一步研究以确定最合适的血压管理策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Current guidelines recommend that rapid systolic blood pressure (SBP) lowering to 140 mmHg may be considered in intracerebral hemorrhage (ICH) patients regardless of initial SBP. However, limited safety data exist in patients presenting with varying degrees of severe hypertension. The purpose of this study was to determine whether there was an increased risk of acute kidney injury (AKI) based upon degree of presentation hypertension in ICH patients whose blood pressure was reduced intensively.

METHODS: This retrospective, cohort study evaluated ICH patients treated with intensive blood pressure control (SBP ≤140 mmHg) who presented with three degrees of presentation hypertension: mild (SBP 141-179 mmHg), moderate (SBP 180-219 mmHg), and severe (SBP ≥ 220 mmHg). Univariate analysis of demographics variables, ICH severity, and factors known to impact AKI was conducted between the three groups. Post hoc testing was used to compare differences between specific groups, with a Bonferroni correction adjusting for multiple comparisons. Additionally, we conducted logistic regression analysis to determine whether baseline SBP group independently predicted AKI.

RESULTS: We included 401 patients (177 with mild, 124 with moderate, and 100 with severe hypertension). There was a significant increase in the prevalence of AKI between groups, with the severe group experiencing the highest rate (p < 0.001). The presence of severe hypertension was also found to independently predict AKI development (odds ratio 2.6; p < 0.001).

CONCLUSION: Our study observed higher rates of AKI in patients presenting with severe hypertension. Further research is needed to determine the most appropriate strategies for managing blood pressure in ICH patients presenting with higher SBP.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Hewgley H, Turner SC, Vandigo JE, et al. Impact of Admission Hypertension on Rates of Acute Kidney Injury in Intracerebral Hemorrhage Treated with Intensive Blood Pressure Control. Neurocrit Care. 2018. PMID: 29327151. doi:10.1007/s12028-017-0488-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。